<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Reversible Hypopigmentation with Pazopanib

descriptionPublicationkeyboard_double_arrow_right Article 01 Oct 2018 English Publisher:Georg Thieme Verlag KGJournal:Indian Journal of Medical and Paediatric Oncology, volume 39, pages 519-520 (issn: 0971-5851, eissn: 0975-2129,

Authors: Bhanu Prakash Lalkota; Radheshyam Naik; Pramod S Chindar; B. J. Srinivasa;

doi: 10.4103/ijmpo.ijmpo_104_17

Reversible Hypopigmentation with Pazopanib

- Summary
- Subjects
- Metrics

Abstract

AbstractTablet Pazopanib known to cause Hypo pigmentation and Hyperpigmentation as per various literature reports. We report here a case of reversible hypopigmentation with Pazopanib in a patient treated for spindle cell sarcoma. Patient did not have any clinical symptoms except for cosmetic significance.

Keywords

reversible, tyrosine kinase inhibitor, Pazopanib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, hypopigmentation, RC254-282

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average